Mankind Pharma pledges 56.31% equity in Bharat Serums for NCDs

    Synopsis:

    Mankind Pharma pledged 56.31% of its shares in Bharat Serums for ₹5,000 crore NCDs. Mankind Pharma share price rose 1%, settling at ₹2,918.55, with a 46% one-year return.

    Mankind Pharma news today

    Mankind Pharma has pledged an additional 56.31% equity shares of Bharat Serums and Vaccines Ltd (BSV), its wholly owned subsidiary, in favour of Catalyst Trusteeship Ltd. This move secures its listed, rated, and redeemable non-convertible debentures (NCDs) worth ₹5,000 crore, issued in three series. The pledge strengthens the security framework for NCD holders and demonstrates Mankind Pharma’s commitment to meeting its financial obligations.

    Also read: M&M unveils BE 6 and XEV 9e Pack Three at ₹26.9 lakh and ₹30.5 lakh

    Mankind Pharma Limited

    Trade

    2528.641.70 (1.67 %)

    Updated - 03 July 2026
    2543.00day high
    DAY HIGH
    2480.20day low
    DAY LOW
    392427
    VOLUME (BSE)

    Key takeaways

    • Equity pledged: 56.31% of BSV shares

    • Subsidiary: Bharat Serums and Vaccines Ltd (BSV)

    • NCD value: ₹5,000 crore

    • Debenture trust deeds date: 10 October 2024

    • Trustee: Catalyst Trusteeship Ltd

    Also read: Tata Steel reports 6.17% rise in India’s steel production in Q3FY25

    Catalyst Trusteeship secures NCDs

    Catalyst Trusteeship Ltd acts as the Common Security Trustee for the NCD holders, ensuring that the pledged equity serves as collateral for the debentures. This arrangement is part of the agreements executed in October 2024, highlighting Mankind Pharma’s strategic approach to managing its financial instruments.

    Mankind Pharma’s financial performance

    Mankind Pharma continues to deliver strong market performance. The Mankind Pharma share price rose by over 1% to ₹2,918.55 on the BSE. The company’s stock has provided a one-year return of nearly 46%, reflecting investor confidence in its growth trajectory.

    NCD Details

    Parameter

    Details

    NCD Value

    ₹5,000 crore

    Number of Series

    3

    Trustee

    Catalyst Trusteeship Ltd

    Equity Pledged

    56.31% of BSV shares

    Debenture Deed Date

    10 October 2024

    Mankind Pharma share price trends

    The Mankind Pharma share price has shown resilience, reflecting positive sentiment in the market. With a 46% one-year return, the stock has outperformed expectations, underscoring the company’s robust financial position and strategic moves.

    Mankind Pharma’s pledge of additional equity in Bharat Serums strengthens its financial security and showcases its commitment to fulfilling NCD-related obligations.

    Also read: NTPC enters nuclear energy business with NPUNL incorporation

    Do you have a trading account app or demat account app?

    You can open an account with Bajaj Broking in minutes.

    Download the Bajaj Broking app now from Play Store or App Store.

    Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

    This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

    For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

    Share this article: 

    Published Date : 08 Jan 2025

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |